News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–5
Matches
5
Sources here
1
Companies here
1
Search results Stored financial headlines

Active search

5 matching headlines

Ticker or company: GALDMain company stories
Clear
Latest

finance.yahoo.com Regulatory and legal

Galderma Receives European Union Approval for Restylane® Shaype™: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping

Galderma has introduced the first-and-only shaper to the hyaluronic acid (HA) market with Restylane Shaype, now approved in the European Union (EU) for chin augmentation1 Restylane Shaype is the firmest HA gel available, powered by new NASHA HD™ technology, engineered to build and shape on bone for instant, natural-looking lower-face shaping from any angle1-3 It is the latest …

Main company 🇨🇭 Switzerland
Read at finance.yahoo.com
Sharemaestro market context Trend signal active 52 weeks +28.1% · Next-week setup positive 67.6% GALD stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Just inNext headlines
finance.yahoo.com Earnings Main company 🇨🇭 Switzerland

Morgan Stanley bullish on Galderma on stronger Nemluvio growth outlook

Investing.com -- Morgan Stanley on Thursday upgraded Galderma Group AG to "overweight" from "equal-weight" and raised its price target to 210 Swiss francs from 160 Swiss francs, citing higher growth forecasts for the company's Nemluvio drug and injectable aesthetics business after the Swiss dermatology …

GALD main company
Sharemaestro market context Trend signal active 52 weeks +28.1% · Next-week setup positive 67.6% GALD stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Earnings Main company 🇨🇭 Switzerland

Galderma Group AG (GDERF) Half Year 2026 Earnings Call Highlights: Record Sales and Strategic ...

This article first appeared on GuruFocus. Release Date: July 23, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Galderma Group AG (GDERF) delivered record net sales of USD 3.1 billion in the first …

GALD main company
Sharemaestro market context Trend signal active 52 weeks +28.1% · Next-week setup positive 67.6% GALD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

finance.yahoo.com Earnings Main company 🇨🇭 Switzerland

Galderma Reports Record First Half 2026 Net Sales of 3.134 Billion USD and 24.6% Year-on-Year Growth at Constant Currency, Raises Net Sales Guidance for the Full Year

Ad hoc announcement pursuant to Art. 53 LR ZUG, Switzerland, July 23, 2026--(BUSINESS WIRE)--Galderma Group AG (SIX: GALD), the pure-play dermatology category leader, today announced its financial results for the first half of 2026. Net sales reached 3.134 billion USD, surpassing 3 billion USD …

GALD main company
Sharemaestro market context Trend signal active 52 weeks +28.1% · Next-week setup positive 67.6% GALD stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Macro sensitivity Main company 🇨🇭 Switzerland

Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region

Galderma launches Alastin, its premium regenerative skincare brand into Japan, Singapore, South Korea and Taiwan The Japan and Asia Pacific (JPAC) region is among the fastest‑growing markets globally for medical aesthetics and dermatological skincare, driven by rising adoption of minimally invasive procedures and an …

GALD main company
Sharemaestro market context Trend signal active 52 weeks +28.1% · Next-week setup positive 67.6% GALD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context